Managing Minimally Abnormal Cervical Cancer Screening Results

This JAMA Insights review summarizes 2020 consensus guidelines on management of minimally abnormal cervical cancer screening results, including no abnormal pathology, atypical squamous cells of undetermined significance (ASCUS), and low-grade squamous intraepithelial lesion (LSIL) with and without positive high-risk HPV testing.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research